RSS Feed - Crisis Management - Kaye Scholer LLP
Current Feed: http://www.kayescholer.com/practice/rss.xml?p=crisis_management
Zaldwaynaka (Z) Scott (08/19/14)
Zaldwaynaka (Z) Scott is Co-Chair of Kaye Scholer’s Chicago White Collar Litigation and Internal Investigations Practice. Z is a seasoned trial lawyer, having taken more than 40 mostly jury trials to verdict in federal court. She concentrates her practice on complex commercial litigation, corporate internal investigations (including matters related to the Foreign Corrupt Practices Act), counseling on corporate compliance matters and white collar criminal defense. Her federal civil and criminal litigation experience includes accounting and commercial fraud, public corruption, civil tax appeals and criminal tax prosecutions, money-laundering and investment, and financial institution fraud. She has also led and represented companies in complex and extensive government regulatory and criminal grand jury investigations. Z has experience in appellate practice and has briefed and argued cases before the Seventh Circuit Court of Appeals.
Amy J. Conway-Hatcher (08/19/14)
Amy Conway-Hatcher is a Partner in Kaye Scholer’s Complex Commercial Litigation Department, and is head of the White Collar Litigation and Internal Investigations Practice in Washington, DC. Amy’s practice focuses on corporate internal investigations, corporate compliance and defending corporate and individual clients in criminal and civil enforcement matters. She has appeared before the Department of Justice, US Attorneys’ Offices, the Securities and Exchange Commission, the US Commerce Department, the Department of Treasury’s Office of Foreign Assets Control (OFAC), the New York Attorney General’s Office, as well as other federal and state regulators.
Vincent A. Sama (08/19/14)
Vincent Sama is Co-Chair of the Litigation Department, Chair of the Securities and Derivative Litigation Practice Group and a member of the firm's Executive Committee. He concentrates his practice in complex commercial litigation, securities and derivative litigation, internal and government investigations, international commercial disputes and arbitration.
Diane Holt Frankle (08/18/14)
Diane Frankle represents publicly traded and privately held companies engaged in a wide variety of US and cross-border mergers, acquisitions, strategic alliances and joint ventures. Diane has completed more than 100 M&A deals with a total value exceeding $12 billion during the last 25 years. Her focus clients include companies in the technology, life sciences and health care industries, including those in software, internet security, storage, biotech, medical device, semiconductor, pharmaceutical and other sectors.
Adam Golodner (08/08/14)
Adam Golodner is a Partner in our Complex Commercial Litigation Department and the Leader of our Global Cybersecurity & Privacy Group. With a unique career spanning more than 20 years of leadership positions in business, academia and government, Adam is well recognized for providing high-impact strategic advice and resolving complex issues at the intersection of law, security, policy, technology, innovation and economics. He has deep experience with the issues facing private and public-sector clients in critical information infrastructure sectors and focuses on existing and proposed cybersecurity laws and policies and related national security, consumer protection and privacy issues. Adam has been quoted in The Wall Street Journal, the New York Times, Agenda (a Financial Times publication), Global Competition Review, Global Investigations Review and Federal Computer Week. He also advises on regulatory and compliance matters, including in the antitrust arena, helping clients to develop effective and efficient programs and representing them in investigations and related litigation brought by various US and international regulatory regimes.
Arthur E. Brown (06/18/14)
Arthur E. Brown is Co-Chair of Kaye Scholer’s Product Liability Group, and a member of the firm’s Complex Commercial Litigation Group. His practice focuses on representing and advising clients on mass tort and product liability issues, investigations by federal and state authorities, inquiries from Congress and commercial litigation disputes. As part of his practice, Arthur frequently serves as national counsel representing pharmaceutical companies in mass tort product liability actions, advises clients on strategic litigation and settlement decisions in the areas of commercial litigation and white collar investigations, and counsels clients on litigation avoidance.
Joel I. Greenberg (05/07/14)
Joel Greenberg is the Senior Corporate Partner and Chair of the Canada Group at Kaye Scholer. He concentrates in U.S. and cross-border mergers and acquisitions of public and private companies, representation of financial sponsors, and securities transactions. He also advises publicly held and private companies on a wide variety of corporate governance and day-to-day corporate as well as transactional matters. He is a former Chair (2006–2009) of the Committee on Mergers & Acquisitions of the American Bar Association Section of Business Law.
Dr. Sebastian Jungermann (05/06/14)
Dr. Sebastian Jungermann ist Partner von Kaye Scholer, er leitet die deutsche Kartellrechtspraxis. Herr Jungermann berät nationale und internationale Mandanten zu allen Fragen des deutschen und europäischen Kartellrechts, insbesondere auch im Rahmen der Fusionskontrolle vor dem Bundeskartellamt, der EU Kommission, und bei multinationalen Anmeldungen, im Rahmen von Kartellverfahren, Bußgeldverfahren, Kartellstrafverfahren, der Missbrauchskontrolle, Kronzeugenstrategien und -anträge, kartellrechtliche Compliance, interne Untersuchungen, Klageverfahren sowie im Bereich vertragliche Wettbewerbsbeschränkungen. Herr Jungermann vertritt seine Mandanten bei Gericht und vor den Kartellbehörden in Deutschland, der Europäischen Kommission und dem US Department of Justice. Zudem berät Herr Jungermann auch auf den Gebieten des Gesellschaftsrechts, Technologierechts und der Compliance sowie bei grenzüberschreitenden Verfahren und im Rahmen der US Pre-Trial Discovery.